IL199622A0 - Foxp3 peptide vaccine - Google Patents

Foxp3 peptide vaccine

Info

Publication number
IL199622A0
IL199622A0 IL199622A IL19962209A IL199622A0 IL 199622 A0 IL199622 A0 IL 199622A0 IL 199622 A IL199622 A IL 199622A IL 19962209 A IL19962209 A IL 19962209A IL 199622 A0 IL199622 A0 IL 199622A0
Authority
IL
Israel
Prior art keywords
peptide vaccine
foxp3 peptide
foxp3
vaccine
peptide
Prior art date
Application number
IL199622A
Other languages
English (en)
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of IL199622A0 publication Critical patent/IL199622A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL199622A 2007-01-03 2009-06-30 Foxp3 peptide vaccine IL199622A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87861507P 2007-01-03 2007-01-03
US89647207P 2007-03-22 2007-03-22
PCT/JP2007/001466 WO2008081581A1 (en) 2007-01-03 2007-12-26 Foxp3 peptide vaccine

Publications (1)

Publication Number Publication Date
IL199622A0 true IL199622A0 (en) 2010-04-15

Family

ID=39588270

Family Applications (1)

Application Number Title Priority Date Filing Date
IL199622A IL199622A0 (en) 2007-01-03 2009-06-30 Foxp3 peptide vaccine

Country Status (14)

Country Link
US (1) US8563516B2 (cg-RX-API-DMAC7.html)
EP (2) EP2481748A3 (cg-RX-API-DMAC7.html)
JP (1) JP5339375B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090099075A (cg-RX-API-DMAC7.html)
CN (1) CN101641369B (cg-RX-API-DMAC7.html)
AU (1) AU2007340834B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0720794A2 (cg-RX-API-DMAC7.html)
CA (1) CA2674365A1 (cg-RX-API-DMAC7.html)
IL (1) IL199622A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009007261A (cg-RX-API-DMAC7.html)
RU (1) RU2473557C2 (cg-RX-API-DMAC7.html)
SG (1) SG177199A1 (cg-RX-API-DMAC7.html)
TW (1) TWI441648B (cg-RX-API-DMAC7.html)
WO (1) WO2008081581A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009050486A2 (en) * 2007-10-19 2009-04-23 The University Of Surrey Peptide manipulators of regulatory t cell activity
CZ301144B6 (cs) * 2008-09-15 2009-11-18 Vysoká škola chemicko technologická v Praze Príprava monoklonálních protilátek proti FoxP3 proteinu s použitím modifikovaných virum podobných cástic Masonova-Pfizerova opicího viru
MX2011006755A (es) * 2008-12-24 2011-07-20 Oncotherapy Science Inc Peptidos clorf59 y vacunas que los incluyen.
TWI507204B (zh) * 2009-05-26 2015-11-11 Oncotherapy Science Inc Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
AU2012296090B2 (en) * 2011-08-12 2015-05-14 Oncotherapy Science, Inc. MPHOSPH1 peptides and vaccines including the same
CN102603892B (zh) * 2012-02-22 2013-10-30 尉军 一种肿瘤标志物foxp3抗原多肽及应用
JP7022067B2 (ja) * 2016-01-14 2022-02-17 メモリアル スローン ケタリング キャンサー センター Ｆｏｘｐ３由来のペプチドに特異的なｔ細胞受容体様抗体
CN111375055B (zh) * 2020-02-20 2021-09-03 陈宛莎 一种2019-nCoV亚单位疫苗组合物及其免疫方法
WO2025136809A2 (en) * 2023-12-19 2025-06-26 Regeneron Pharmaceuticals, Inc. Foxp3 peptides and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3939746B2 (ja) 1991-07-25 2007-07-04 バイオジェン・アイデック・インコーポレイテッド 細胞毒性ｔ−リンパ球応答の誘導
WO2002090600A2 (en) * 2001-05-08 2002-11-14 Darwin Molecular Corporation A method for regulating immune function in primates using the foxp3 protein
CN103073620B (zh) 2002-09-12 2014-12-10 肿瘤疗法科学股份有限公司 Kdr肽和包括该肽的疫苗
GB0417430D0 (en) 2004-08-05 2004-09-08 Uc3 A novel HPV vaccine comprising peptides from host cell proteins
JP4628208B2 (ja) 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Ｃｘａｄｒｌ１またはｇｃｕｄ１タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
JP4840866B2 (ja) 2005-01-19 2011-12-21 学校法人慶應義塾 癌ワクチン

Also Published As

Publication number Publication date
TWI441648B (zh) 2014-06-21
CN101641369A (zh) 2010-02-03
US8563516B2 (en) 2013-10-22
KR20090099075A (ko) 2009-09-21
JP5339375B2 (ja) 2013-11-13
JP2010514669A (ja) 2010-05-06
CN101641369B (zh) 2014-10-22
US20100092501A1 (en) 2010-04-15
AU2007340834A1 (en) 2008-07-10
EP2114987A4 (en) 2010-07-21
CA2674365A1 (en) 2008-07-10
EP2481748A2 (en) 2012-08-01
EP2481748A3 (en) 2012-10-24
WO2008081581A1 (en) 2008-07-10
EP2114987A1 (en) 2009-11-11
SG177199A1 (en) 2012-01-30
RU2473557C2 (ru) 2013-01-27
TW200835516A (en) 2008-09-01
BRPI0720794A2 (pt) 2014-03-11
RU2009129531A (ru) 2011-02-10
MX2009007261A (es) 2009-11-11
AU2007340834B2 (en) 2013-02-28

Similar Documents

Publication Publication Date Title
IL219048A (en) Peptide compounds derived from urcl10
IL199663A0 (en) Vaccine
IL201782A0 (en) Vaccine
GB0607088D0 (en) Vaccine
IL203899A (en) Foxm1-derived peptide compounds
GB0717911D0 (en) Vaccine
EP2056861A4 (en) IMPF-IMMUNOTHERAPY
GB0711858D0 (en) Vaccine
IL206307A0 (en) Vaccine
AP2010005166A0 (en) Vaccines
IL199622A0 (en) Foxp3 peptide vaccine
GB0700135D0 (en) Vaccine
GB0710538D0 (en) Vaccine
ZA201003851B (en) Vaccine
GB0617602D0 (en) Vaccine
GB0709373D0 (en) BCG-based anti-atheroma vaccine
HK1132753A (en) Foxp3 peptide vaccine
GB0716224D0 (en) Peptides for vaccine
GB0700760D0 (en) Vaccine
GB0721928D0 (en) Vaccine
GB0711357D0 (en) Vaccine
GB0712062D0 (en) Vaccine
GB0708522D0 (en) Vaccine
GB0712658D0 (en) Vaccine
GB0712435D0 (en) Vaccine